Skip to main content

News

NextGen Cancer Science Seminar - April 15

 

More information and a recording of the talk is available below.

For questions about this event, please reach out to Mary Hindle at hindlem@health.missouri.edu

The Evolving Role of Precision Medicine in Lung Cancer

Description

Headshot of Dr. Richard Hammer

Presented by Dr. Richard Hammer, Vice-Chair of Clinical Affairs, Dept of Pathology & Anatomical Sciences, and Kali Dougherty MS, CGC (Foundation Medicine)

The seminar:
•    Outlines the clinical implications of tumor testing strategies for patients with lung cancer, including comprehensive genomic profiling, hotspot analysis, tissue and liquid biopsies
•    Identifies the role of multidisciplinary teams in facilitation and implementation of molecular testing in oncology care settings
•    Assesses methods to overcome barriers to personalized medicine and increase molecular testing, tumor boards, and clinical trial referral in the community setting
•    Applies available molecular testing to develop evidence-based individualized treatment decisions for cancer patients
•    Reviews recent advancements in comprehensive genomic profiling for advanced lung cancer
•    Discusses potential applications of liquid biopsy for patients with advanced lung cancer and r
eview available resources for physicians utilizing comprehensive genomic profiling